Free Trial

iRhythm Technologies (IRTC) Competitors

iRhythm Technologies logo
$175.61 +1.80 (+1.04%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$175.72 +0.11 (+0.06%)
As of 10/3/2025 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IRTC vs. ZBH, SNN, SOLV, PEN, STVN, BLCO, GKOS, TMDX, SLNO, and NVST

Should you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), and Envista (NVST). These companies are all part of the "medical equipment" industry.

iRhythm Technologies vs. Its Competitors

iRhythm Technologies (NASDAQ:IRTC) and Zimmer Biomet (NYSE:ZBH) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

88.9% of Zimmer Biomet shares are owned by institutional investors. 0.7% of iRhythm Technologies shares are owned by company insiders. Comparatively, 0.7% of Zimmer Biomet shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Zimmer Biomet has a net margin of 10.51% compared to iRhythm Technologies' net margin of -14.06%. Zimmer Biomet's return on equity of 12.76% beat iRhythm Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
iRhythm Technologies-14.06% -90.03% -8.52%
Zimmer Biomet 10.51%12.76%7.21%

iRhythm Technologies has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500. Comparatively, Zimmer Biomet has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500.

iRhythm Technologies currently has a consensus price target of $172.17, suggesting a potential downside of 1.96%. Zimmer Biomet has a consensus price target of $112.44, suggesting a potential upside of 11.54%. Given Zimmer Biomet's higher possible upside, analysts plainly believe Zimmer Biomet is more favorable than iRhythm Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iRhythm Technologies
1 Sell rating(s)
2 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.79
Zimmer Biomet
2 Sell rating(s)
8 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.48

Zimmer Biomet has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iRhythm Technologies$591.84M9.53-$113.29M-$2.93-59.94
Zimmer Biomet$7.68B2.60$903.70M$4.1124.53

In the previous week, iRhythm Technologies had 9 more articles in the media than Zimmer Biomet. MarketBeat recorded 16 mentions for iRhythm Technologies and 7 mentions for Zimmer Biomet. Zimmer Biomet's average media sentiment score of 1.16 beat iRhythm Technologies' score of 0.60 indicating that Zimmer Biomet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
iRhythm Technologies
5 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Zimmer Biomet
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Zimmer Biomet beats iRhythm Technologies on 10 of the 14 factors compared between the two stocks.

Get iRhythm Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IRTC vs. The Competition

MetriciRhythm TechnologiesMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$5.64B$2.23B$6.12B$10.58B
Dividend YieldN/AN/A5.65%4.70%
P/E RatioN/A39.3386.9626.71
Price / Sales9.5311.78605.42130.98
Price / CashN/A60.2037.9061.31
Price / Book60.5612.0512.556.55
Net Income-$113.29M-$64.84M$3.31B$277.50M
7 Day Performance2.81%3.27%4.28%2.42%
1 Month Performance-3.00%6.33%6.90%8.63%
1 Year Performance180.04%34.71%70.54%31.60%

iRhythm Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IRTC
iRhythm Technologies
1.1548 of 5 stars
$175.61
+1.0%
$172.17
-2.0%
+180.0%$5.64B$591.84M0.002,000Analyst Forecast
ZBH
Zimmer Biomet
4.6844 of 5 stars
$98.18
+1.2%
$113.16
+15.3%
-3.7%$19.45B$7.68B23.8917,000Positive News
Ex-Dividend
SNN
Smith & Nephew SNATS
3.428 of 5 stars
$35.44
+0.5%
$36.00
+1.6%
+21.2%$15.43B$5.81B16.4117,349Positive News
Analyst Downgrade
SOLV
Solventum
2.656 of 5 stars
$71.43
+1.4%
$85.44
+19.6%
+9.3%$12.39B$8.25B33.0722,000Analyst Forecast
PEN
Penumbra
4.6866 of 5 stars
$253.64
+1.8%
$302.93
+19.4%
+31.5%$9.89B$1.19B67.464,500News Coverage
Analyst Forecast
Insider Trade
STVN
Stevanato Group
2.3752 of 5 stars
€25.59
+2.0%
N/A+37.3%€7.75B€1.19B47.395,521
BLCO
Bausch + Lomb
1.8778 of 5 stars
$14.47
+0.7%
$15.56
+7.5%
-20.1%$5.12B$4.89B-18.5413,500News Coverage
Analyst Forecast
GKOS
Glaukos
4.5685 of 5 stars
$79.95
-1.9%
$123.58
+54.6%
-33.2%$4.59B$383.48M-48.45780Analyst Forecast
TMDX
TransMedics Group
3.2436 of 5 stars
$113.87
0.0%
$125.40
+10.1%
-16.8%$3.88B$441.54M59.00210Positive News
SLNO
Soleno Therapeutics
4.1794 of 5 stars
$64.96
+3.6%
$115.09
+77.2%
+19.3%$3.45BN/A-15.6930
NVST
Envista
3.6888 of 5 stars
$20.34
+1.8%
$20.92
+2.9%
+10.7%$3.38B$2.51B63.5712,300

Related Companies and Tools


This page (NASDAQ:IRTC) was last updated on 10/5/2025 by MarketBeat.com Staff
From Our Partners